Guideline Review: EASL Clinical Practice Guidelines: Drug-Induced Liver Injury (DILI)

Paul N. Brennan (Lead / Corresponding author), Peter Cartlidge, Thomas Manship, John F. Dillon

Research output: Contribution to journalArticlepeer-review

3 Downloads (Pure)

Abstract

The European Association for the Study of the Liver has produced extensive guidelines for the investigation and management of drug-induced liver injury. Here, we provide a commentary and overview of some of the principle disease investigations and management that arise from these guideline recommendations.

Original languageEnglish
Number of pages5
JournalFrontline Gastroenterology
Early online date29 Jul 2021
DOIs
Publication statusE-pub ahead of print - 29 Jul 2021

Keywords

  • drug induced hepatotoxicity
  • drug induced liver injury
  • drug metabolism
  • drug toxicity

Fingerprint

Dive into the research topics of 'Guideline Review: EASL Clinical Practice Guidelines: Drug-Induced Liver Injury (DILI)'. Together they form a unique fingerprint.

Cite this